These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 18498876)

  • 1. Cyclooxygenase-2 induces genomic instability, BCL2 expression, doxorubicin resistance, and altered cancer-initiating cell phenotype in MCF7 breast cancer cells.
    Singh B; Cook KR; Vincent L; Hall CS; Berry JA; Multani AS; Lucci A
    J Surg Res; 2008 Jun; 147(2):240-6. PubMed ID: 18498876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 expression induces genomic instability in MCF10A breast epithelial cells.
    Singh B; Vincent L; Berry JA; Multani AS; Lucci A
    J Surg Res; 2007 Jun; 140(2):220-6. PubMed ID: 17418864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
    Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
    Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential responses to doxorubicin-induced phosphorylation and activation of Akt in human breast cancer cells.
    Li X; Lu Y; Liang K; Liu B; Fan Z
    Breast Cancer Res; 2005; 7(5):R589-97. PubMed ID: 16168102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl2-negative MCF7 cells overexpress p53: implications for the cell cycle and sensitivity to cytotoxic drugs.
    Poliseno L; Mariani L; Collecchi P; Piras A; Zaccaro L; Rainaldi G
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):127-30. PubMed ID: 12172977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of 14-3-3sigma as a contributor to drug resistance in human breast cancer cells using functional proteomic analysis.
    Liu Y; Liu H; Han B; Zhang JT
    Cancer Res; 2006 Mar; 66(6):3248-55. PubMed ID: 16540677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects and mechanism of downregulation of COX‑2 expression by RNA interference on proliferation and apoptosis of human breast cancer MCF‑7 cells.
    Han H; Yang S; Lin SG; Xu CS; Han ZH
    Mol Med Rep; 2014 Dec; 10(6):3092-8. PubMed ID: 25323004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcl-2 slows in vitro breast cancer growth despite its antiapoptotic effect.
    Knowlton K; Mancini M; Creason S; Morales C; Hockenbery D; Anderson BO
    J Surg Res; 1998 Apr; 76(1):22-6. PubMed ID: 9695733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linalool, a plant-derived monoterpene alcohol, reverses doxorubicin resistance in human breast adenocarcinoma cells.
    Ravizza R; Gariboldi MB; Molteni R; Monti E
    Oncol Rep; 2008 Sep; 20(3):625-30. PubMed ID: 18695915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cox-2 expression on tissue microarray of breast cancer.
    Park K; Han S; Shin E; Kim HJ; Kim JY
    Eur J Surg Oncol; 2006 Dec; 32(10):1093-6. PubMed ID: 16797158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer.
    Mehta K; Fok J; Miller FR; Koul D; Sahin AA
    Clin Cancer Res; 2004 Dec; 10(23):8068-76. PubMed ID: 15585642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COX-2 overexpression increases motility and invasion of breast cancer cells.
    Singh B; Berry JA; Shoher A; Ramakrishnan V; Lucci A
    Int J Oncol; 2005 May; 26(5):1393-9. PubMed ID: 15809733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer.
    Kawasaki K; Watanabe M; Sakaguchi M; Ogasawara Y; Ochiai K; Nasu Y; Doihara H; Kashiwakura Y; Huh NH; Kumon H; Date H
    Cancer Gene Ther; 2009 Jan; 16(1):65-72. PubMed ID: 18654608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival.
    Györffy B; Serra V; Jürchott K; Abdul-Ghani R; Garber M; Stein U; Petersen I; Lage H; Dietel M; Schäfer R
    Oncogene; 2005 Nov; 24(51):7542-51. PubMed ID: 16044152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential modulation by estradiol of P-glycoprotein drug resistance protein expression in cultured MCF7 and T47D breast cancer cells.
    Zampieri L; Bianchi P; Ruff P; Arbuthnot P
    Anticancer Res; 2002; 22(4):2253-9. PubMed ID: 12174911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer.
    Tabuchi Y; Matsuoka J; Gunduz M; Imada T; Ono R; Ito M; Motoki T; Yamatsuji T; Shirakawa Y; Takaoka M; Haisa M; Tanaka N; Kurebayashi J; Jordan VC; Naomoto Y
    Int J Oncol; 2009 Feb; 34(2):313-9. PubMed ID: 19148464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COX-2 induces IL-11 production in human breast cancer cells.
    Singh B; Berry JA; Shoher A; Lucci A
    J Surg Res; 2006 Apr; 131(2):267-75. PubMed ID: 16457848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progesterone sensitizes breast cancer MCF7 cells to imatinib inhibitory effects.
    Rocha A; Azevedo I; Soares R
    J Cell Biochem; 2008 Feb; 103(2):607-14. PubMed ID: 17614352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long duration exposure to cadmium leads to increased cell survival, decreased DNA repair capacity, and genomic instability in mouse testicular Leydig cells.
    Singh KP; Kumari R; Pevey C; Jackson D; DuMond JW
    Cancer Lett; 2009 Jun; 279(1):84-92. PubMed ID: 19232459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early upregulation of cyclooxygenase-2 in human papillomavirus type 16 and telomerase-induced immortalization of human esophageal epithelial cells.
    Zhuang ZH; Tsao SW; Deng W; Wang JD; Xia HH; He H; Feng HC; Wang LD; Gu Q; Lam SK; Lin MC; Kung HF; Wong BC
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1613-20. PubMed ID: 18717758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.